Matinas BioPharma

MTNB • AMEX • Stock Fundamentals

Matinas BioPharma is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Jerome D. Jabbour, with a market cap of $5.2M.

Market Cap$5.2M

Employees34.0

CEOJerome D. Jabbour

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 8, 2026 · 1 month 6 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Matinas BioPharma

Matinas BioPharma (MTNB) has a market capitalization of $5.2M and trades on AMEX.

Matinas BioPharma has approximately 34 employees.